Last 12 months
Inside the activity.
0 purchase rows · 74 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 7 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2020 Filed Sep 1, 2020 15:50 UTC |
Curet MyriamEVP & Chief Medical Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,510 | $0.00 Strike: $727.01 | $0.00 |
DisclosureSEC source: 0001035267-20-000150 · edgardoc.xml · derivative · entry 1 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,510 Underlying: Common Stock · 4,510 shares Expires 2030-08-28 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 15:55 UTC |
Curet MyriamEVP & Chief Medical Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,510 | $0.00 Strike: $727.01 | $0.00 |
DisclosureSEC source: 0001035267-20-000152 · edgardoc.xml · derivative · entry 1 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,510 Underlying: Common Stock · 4,510 shares Expires 2030-08-28 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 16:06 UTC |
DeSantis RobertExecutive VP & GM IA&E
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,449 | $0.00 Strike: $727.01 | $0.00 |
DisclosureSEC source: 0001035267-20-000154 · edgardoc.xml · derivative · entry 1 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,449 Underlying: Common Stock · 1,449 shares Expires 2030-08-28 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 16:57 UTC |
MOHR MARSHALLExecutive VP & CFO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,510 | $0.00 Strike: $727.01 | $0.00 |
DisclosureSEC source: 0001035267-20-000156 · edgardoc.xml · derivative · entry 1 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,510 Underlying: Common Stock · 4,510 shares Expires 2030-08-28 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 21:37 UTC |
Johnson Amal MDirector
|
GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-20-000138 · edgardoc.xml · nonDerivative · entry 1 Johnson Amal M · CIK 0001388397 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468 F1 · kind: This transaction involved a gift of securities by the reporting person to her daughter, who lives outside of the reporting person's household. The reporting person no longer has beneficial ownership of these shares. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 15:11 UTC |
Curet MyriamEVP & Chief Medical Officer
|
GiftCommon Stock | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-20-000136 · edgardoc.xml · nonDerivative · entry 1 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,986 F1 · kind: These shares were gifted to the Bryn Mawr College. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:59 UTC |
Rosa David J.EVP and Chief Business Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $113.73 | $0.00 |
DisclosureSEC source: 0001035267-20-000134 · edgardoc.xml · derivative · entry 3 Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:59 UTC |
Rosa David J.EVP and Chief Business Officer
|
SaleCommon Stock | 16,840 | $693.02 | $11,670,416.38 |
DisclosureSEC source: 0001035267-20-000134 · edgardoc.xml · nonDerivative · entry 2 Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,479 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021. F2 · price: The average selling price for the transaction was $693.017550. The shares sold at $685.32 - $655.54 = 200 shares; $686.75 = 600 shares; $687.65 = 320 shares; $689.245 - $689.79 = 1,100 shares; $690.493 = 200 shares; $691.00 - $$691.90 = 1,906 shares; $692.279 - $693.018 = 2,443 shares; $693.06 - $$693.97 = 2,432 shares; $694.20 - $694.99 = 4,179 shares; $695.00 - $695.82 = 2,915 shares; $696.44 - $696.51 = 345 shares; $697 = 200 shares Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:59 UTC |
Rosa David J.EVP and Chief Business Officer
|
Exercise / conversionCommon Stock | 24,000 | $113.73 | $2,729,520.00 |
DisclosureSEC source: 0001035267-20-000134 · edgardoc.xml · nonDerivative · entry 1 Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 00:42 UTC |
MOHR MARSHALLExecutive VP & CFO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $127.91 | $0.00 |
DisclosureSEC source: 0001035267-20-000132 · edgardoc.xml · derivative · entry 4 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 7,500 shares Expires 2023-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 1, 2020. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 00:42 UTC |
MOHR MARSHALLExecutive VP & CFO
|
SaleCommon Stock | 7,500 | $677.19 | $5,078,930.25 |
DisclosureSEC source: 0001035267-20-000132 · edgardoc.xml · nonDerivative · entry 2 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 1, 2020. F2 · price: The average selling price for the transaction was $677.19071. The shares sold at $670.49 = 500 shares; $673.07 = 120 shares; $674.23 =100 shares; $674.58 = 400 shares; $675 - $675.01 = 950 shares; $676 = 750 shares; $677 - $677.96 = 1,100 shares; $678 - $678.76 = 1,100 shares; $680 - $680.34 = 2,480 shares. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 00:42 UTC |
MOHR MARSHALLExecutive VP & CFO
|
Exercise / conversionCommon Stock | 7,500 | $127.91 | $959,325.00 |
DisclosureSEC source: 0001035267-20-000132 · edgardoc.xml · nonDerivative · entry 1 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 1, 2020. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 22:55 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 450 | $0.00 Strike: $189.74 | $0.00 |
DisclosureSEC source: 0001035267-20-000126 · edgardoc.xml · derivative · entry 6 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 450 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 22:55 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 437 | $0.00 Strike: $178.39 | $0.00 |
DisclosureSEC source: 0001035267-20-000126 · edgardoc.xml · derivative · entry 5 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 437 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 22:55 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 450 | $665.13 | $299,308.50 |
DisclosureSEC source: 0001035267-20-000126 · edgardoc.xml · nonDerivative · entry 4 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,066 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 22:55 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 450 | $189.74 | $85,381.52 |
DisclosureSEC source: 0001035267-20-000126 · edgardoc.xml · nonDerivative · entry 3 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 22:55 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 437 | $665.13 | $290,661.81 |
DisclosureSEC source: 0001035267-20-000126 · edgardoc.xml · nonDerivative · entry 2 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,066 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 22:55 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 437 | $178.39 | $77,954.99 |
DisclosureSEC source: 0001035267-20-000126 · edgardoc.xml · nonDerivative · entry 1 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 26, 2021. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 23:00 UTC |
Ladd Amy LDirector
|
SaleCommon Stock | 55 | $665.13 | $36,582.15 |
DisclosureSEC source: 0001035267-20-000128 · edgardoc.xml · nonDerivative · entry 1 Ladd Amy L · CIK 0001781750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 11, 2021. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC |
DeSantis RobertExecutive VP & GM IA&E
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 382 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · derivative · entry 7 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 382 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The exercise price to the shares underlying this grant is $230.9967, equal to 100% of the closing FMV of the Company on the date of grant. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC |
DeSantis RobertExecutive VP & GM IA&E
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 383 | $0.00 Strike: $178.39 | $0.00 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · derivative · entry 6 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 383 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC |
DeSantis RobertExecutive VP & GM IA&E
|
SaleCommon Stock | 383 | $665.57 | $254,912.77 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 5 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,348 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F3 · price: The average selling price for the transaction was $665.568628. The shares sold at $663.08-$663.42 = 400 shares;$665.13 = 12 shares;$666.66 = 100 shares; $667.65 - $667.65 = 100 shares; 668.98 = 100 shares; $670.44 - $670.47 = 53 shares. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC |
DeSantis RobertExecutive VP & GM IA&E
|
Exercise / conversionCommon Stock | 383 | $178.39 | $68,322.11 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC |
DeSantis RobertExecutive VP & GM IA&E
|
SaleCommon Stock | 382 | $665.57 | $254,247.21 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,348 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F3 · price: The average selling price for the transaction was $665.568628. The shares sold at $663.08-$663.42 = 400 shares;$665.13 = 12 shares;$666.66 = 100 shares; $667.65 - $667.65 = 100 shares; 668.98 = 100 shares; $670.44 - $670.47 = 53 shares. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC |
DeSantis RobertExecutive VP & GM IA&E
|
Exercise / conversionCommon Stock | 382 | $231.00 | $88,240.74 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 14:42 UTC |
DeSantis RobertExecutive VP & GM IA&E
|
SaleCommon Stock | 1,033 | $666.69 | $688,687.88 |
DisclosureSEC source: 0001035267-20-000130 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · Executive VP & GM IA&E 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,348 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021. F2 · price: The average selling price for the transaction was $666.687162. The shares sold at $663.33-$663.42 = 300 shares; $664.75 - $664.84 = 200 shares; $665.13 = 17 shares; $667.65 = 100 shares; $668 = 100 shares; $670.133 - $670.65 = 316 shares. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:10 UTC |
NACHTSHEIM JAMI KDirector
|
SaleCommon Stock | 20 | $663.33 | $13,266.60 |
DisclosureSEC source: 0001035267-20-000109 · edgardoc.xml · nonDerivative · entry 1 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,087 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on October 26, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:13 UTC |
LEVY ALAN JDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,800 | $0.00 Strike: $193.08 | $0.00 |
DisclosureSEC source: 0001035267-20-000111 · edgardoc.xml · derivative · entry 3 LEVY ALAN J · CIK 0001280627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Common Stock · 1,800 shares Expires 2022-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 30, 2020. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:13 UTC |
LEVY ALAN JDirector
|
SaleCommon Stock | 1,800 | $670.71 | $1,207,275.48 |
DisclosureSEC source: 0001035267-20-000111 · edgardoc.xml · nonDerivative · entry 2 LEVY ALAN J · CIK 0001280627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,839 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 30, 2020. F2 · price: The average selling price for the transaction was $670.708645. The shares sold at $663.33= 27 shares;$665.00 = 100 shares;$667.57-$667.74 = 197 shares; $668.66 - $668.93 = 300 shares; $670.07 - $670.38 = 207 shares; $671.89 - $671.99 = 333 shares; $672.64 - 100 shares; $673.11 - $673.57 - 436 shares; $674.21 = 100 shares. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:13 UTC |
LEVY ALAN JDirector
|
Exercise / conversionCommon Stock | 1,800 | $193.08 | $347,544.00 |
DisclosureSEC source: 0001035267-20-000111 · edgardoc.xml · nonDerivative · entry 1 LEVY ALAN J · CIK 0001280627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 30, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 90 | $0.00 Strike: $548.50 | $0.00 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 18 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937 Underlying: Common Stock · 90 shares Expires 2029-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 107 | $0.00 Strike: $522.77 | $0.00 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 17 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683 Underlying: Common Stock · 107 shares Expires 2028-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 91 | $0.00 Strike: $499.87 | $0.00 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 16 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 936 Underlying: Common Stock · 91 shares Expires 2029-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 108 | $0.00 Strike: $418.56 | $0.00 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 15 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683 Underlying: Common Stock · 108 shares Expires 2028-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 178 | $0.00 Strike: $328.46 | $0.00 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 14 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415 Underlying: Common Stock · 178 shares Expires 2027-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 178 | $0.00 Strike: $238.91 | $0.00 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · derivative · entry 13 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416 Underlying: Common Stock · 178 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
SaleCommon Stock | 90 | $663.33 | $59,699.70 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 12 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207 Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionCommon Stock | 90 | $548.50 | $49,365.00 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 11 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
SaleCommon Stock | 91 | $663.33 | $60,363.03 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 10 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207 Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionCommon Stock | 91 | $499.87 | $45,488.17 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 9 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
SaleCommon Stock | 178 | $663.33 | $118,072.74 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 8 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionCommon Stock | 178 | $238.91 | $42,526.57 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 7 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
SaleCommon Stock | 178 | $663.33 | $118,072.74 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 6 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207 Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionCommon Stock | 178 | $328.46 | $58,465.29 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 5 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
SaleCommon Stock | 108 | $663.33 | $71,639.64 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 4 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionCommon Stock | 108 | $418.56 | $45,204.48 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 3 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
SaleCommon Stock | 107 | $663.33 | $70,976.31 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 2 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 19:15 UTC |
Samath JamieSVP of Finance
|
Exercise / conversionCommon Stock | 107 | $522.77 | $55,936.39 |
DisclosureSEC source: 0001035267-20-000113 · edgardoc.xml · nonDerivative · entry 1 Samath Jamie · CIK 0001330269 · SVP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 5, 2020. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 17:38 UTC |
Rosa David J.EVP and Chief Business Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $113.73 | $0.00 |
DisclosureSEC source: 0001035267-20-000103 · edgardoc.xml · derivative · entry 3 Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 17:38 UTC |
Rosa David J.EVP and Chief Business Officer
|
SaleCommon Stock | 17,950 | $553.49 | $9,935,204.74 |
DisclosureSEC source: 0001035267-20-000103 · edgardoc.xml · nonDerivative · entry 2 Rosa David J. · CIK 0001519593 · EVP and Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,319 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13,2021. F2 · price: The average selling price for the transaction was $553.49326. The shares sold at $544.87 = 100 shares; $546.247 - $546.50 = 1,323 shares; $547.20 - $547.87 = 1,100 shares; $548.41 - $548.98 = 525 shares; $549.97 - $549.98 - 1,600 shares; $550.15 - $550.72 = 2,304 shares; $551.02 - $551.709 = 250 shares; $552.31 - $552.31 = 400 shares; $555 - $555.03 = 3,350 shares; $556.34 - $556.88 = 1,156 shares; $557.08 - $557.955 = 2,628 shares; $558 - $558.33 = 3,214 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.